Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-25-037169

Options or other derivatives

  • Director acquired 2,924 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
KLAUSNER ARTHUR J Director 2025-12-02 Grant or award · Stock Options +2,924 2,924 D: show line 1 in the form
Loading xslF345X05/rdgdoc.xml…